None listed
Conditions
Brief summary
This trial seeks to investigate if providing a small financial incentive ($30) will increase the uptake and completion of the hepatitis B vaccine among injecting drug users.
Interventions
Provision of a small financial incentives i.e. $30 will be given after the participant receives the second dose and $30 after the participant receives the third dose of Hepatitis B vaccine. Incentives will be given to participants randomised to the incentive arm only.
Sponsors
The Kirby Institute (formerly the National Centre in HIV Epidemiology and Clinical Research)
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
16 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
1) Aged 16 years and above; 2) Injected drugs at least once in the preceding 6 months; 3) No previous hepatitis B infection, and a maximum of one previous dose of hepatitis B vaccination, or unknown infection and vaccination status, based on self-report and, where available medical records; 4) ability to provide informed consent, to be randomised and attend vaccinations over a period of 3 weeks and attend follow up at 12 weeks post randomisation.
Exclusion criteria
Evidence of natural or vaccine induced immunity; 2) Previous exposure or two+ vaccinations (as identified by self report), where HBV surface antibody =10 mIU/ml; 3) Serious mental or physical illness or disability likely to impact on capacity to complete the study procedures; 4) Insufficient English language skills that will impair ability to give informed consent or provide reliable responses to study interviews/questionnaires; 5) Human Immunodeficiency Virus (HIV) infection; 6) Refusal to be vaccinated against hepatitis B.
Outcome results
None listed